A New Perspective on Metabolic Syndrome with Osteopontin: A Comprehensive Review
Open Access
Abstract
Metabolic syndrome (MetS) imposes a substantial burden on the healthcare systems and economies of countries and is a major public health concern worldwide. MetS is mainly caused by an imbalance between calorie intake and energy expenditure; however, it is recognized that additional variables, such as chronic inflammation, may have the same predictive potential as insulin resistance or MetS components in the genesis of type 2 diabetes and cardiovascular events. More importantly, the early diagnosis or treatment of MetS may significantly reduce the burden on the health systems of the disease with any prevention or biomarker and should not be underestimated. Osteopontin (OPN), also called secreted phosphoprotein 1, is a soluble protein found mostly in body fluids. Studies suggest that serum OPN levels may be an early and new biomarker to predict metabolic and cardiovascular complications significantly associated with some diseases. This review aims to provide specific insight into the new biomarker OPN in MetS. With this purpose, it is examined the link between the MetS cornerstones and OPN. In addition, the interaction between the microbiota and MetS is predicted to be bidirectional, and the microbiota may act as a bridge in this interaction process. Increased OPN levels may have unfavourable consequences for cardiovascular diseases, diabetes, and obesity, all of which are components of MetS. Further studies are required to evaluate the use of OPN levels as a clinical biomarker risk of MetS.Keywords
This publication has 52 references indexed in Scilit:
- Serum osteoprotegerin and osteopontin levels are associated with arterial stiffness and the presence and severity of coronary artery diseaseInternational Journal of Cardiology, 2013
- Differential effects of high-fat-diet rich in lard oil or soybean oil on osteopontin expression and inflammation of adipose tissue in diet-induced obese ratsEuropean Journal of Nutrition, 2012
- Systemic blood osteopontin, endostatin, and E-selectin concentrations after vertical banding surgery in severely obese adultsCytokine, 2011
- Osteopontin Is Required for the Early Onset of High Fat Diet-Induced Insulin Resistance in MicePLOS ONE, 2010
- Plasma concentrations of osteopontin, but not thrombin-cleaved osteopontin, are associated with the presence and severity of nephropathy and coronary artery disease in patients with type 2 diabetes mellitusCardiovascular Diabetology, 2010
- Angiotensin II receptor blocker and statins lower elevated levels of osteopontin in essential hypertension—Results from the EUTOPIA trialAtherosclerosis, 2010
- Neutralization of Osteopontin Inhibits Obesity-Induced Inflammation and Insulin ResistanceDiabetes, 2010
- Osteopontin mediates obesity-induced adipose tissue macrophage infiltration and insulin resistance in miceJournal of Clinical Investigation, 2007
- High-Phosphorus Diet Induces Osteopontin Expression of Renal Tubules in RatsJournal of Clinical Biochemistry and Nutrition, 2007
- Osteopontin/Eta-1 upregulated in Crohn’s disease regulates the Th1 immune responseGut, 2005